−0.4000SEK
−30.36 MSEK
29.96 MSEK
53.13 M
About GLYCOREX TRANSPLANTATION B
Sector
Industry
CEO
Johan Laven
Website
Headquarters
Lund
Founded
1995
ISIN
SE0000524530
FIGI
BBG00JHVT6L3
Glycorex Transplantation AB engages in the research and development in the field of organ transplantation. The firm focuses mainly in kidney transplant and also in liver, heart, pancreas, lung, and stem cell transplant. Its product allows transplantation regardless of the blood types of donors and recipients. The company was founded by Kurt Gösta Ingemar Nilsson in 1996 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0EMN is 2.6622 SEK — it hasn't changed in the past 24 hours. Watch GLYCOREX TRANSPLANTATION AB SER'B'NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange GLYCOREX TRANSPLANTATION AB SER'B'NPV stocks are traded under the ticker 0EMN.
0EMN reached its all-time high on Jan 4, 2018 with the price of 3.1092 SEK, and its all-time low was 2.1854 SEK and was reached on Dec 29, 2017. View more price dynamics on 0EMN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0EMN stock is 0% volatile and has beta coefficient of −0.55. Track GLYCOREX TRANSPLANTATION AB SER'B'NPV stock price on the chart and check out the list of the most volatile stocks — is GLYCOREX TRANSPLANTATION AB SER'B'NPV there?
Today GLYCOREX TRANSPLANTATION AB SER'B'NPV has the market capitalization of 76.44 M, it has increased by 16.52% over the last week.
Yes, you can track GLYCOREX TRANSPLANTATION AB SER'B'NPV financials in yearly and quarterly reports right on TradingView.
0EMN net income for the last quarter is −3.52 M SEK, while the quarter before that showed −16.62 M SEK of net income which accounts for 78.85% change. Track more GLYCOREX TRANSPLANTATION AB SER'B'NPV financial stats to get the full picture.
No, 0EMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLYCOREX TRANSPLANTATION AB SER'B'NPV EBITDA is −8.93 M SEK, and current EBITDA margin is −86.42%. See more stats in GLYCOREX TRANSPLANTATION AB SER'B'NPV financial statements.
Like other stocks, 0EMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLYCOREX TRANSPLANTATION AB SER'B'NPV stock right from TradingView charts — choose your broker and connect to your account.